Terumo and others invests in Osaka cardiomyocyte venture Quorips

Quorips, a Tokyo venture aiming to commercialize allogenic iPS cell derived cardiomyocyte sheets, obtained about 1 billion yen venture capital from Daiichi Sankyo, Terumo, and Kyoto University Innovation Capital.

Terumo press release, July 11, 2018

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny